Upasi studying tea’s efficacy against Covid-19

The United Planters’ Affiliation of Southern India (Upasi) has announced that its Tea Exploration Institute is exploring the possibility of working with tea as a defence from the Coronavirus.

“The Upasi Tea Exploration Institute is exploring the possibility of investigating the antiviral home of Theaflavins-3, a compound abundantly uncovered in black tea and catechins from eco-friendly tea to ward off Coronavirus in collaboration with the Tea Board of India by ICMR,” Chairman of Upasi Tea Committee C Shreedharan reported.

This follows a the latest study by a research team from Indonesia and Thailand that explored the secondary metabolites secreted by crops in tropical locations that can be designed as medications. This team investigated a variety of compounds for their potential to inhibit Covid-19.

“The summary of this study was that along with many compounds, catechin, and epicatechin-gallate sourced from tea (Camellia sinensis) could act as potential inhibitors of Covid-19. Having said that, further more scientific research are expected to show the antiviral homes of tea from Covid-19,” Shreedharan reported.

He also reported that scientists from Taiwan and China have uncovered in a laboratory study that SARS Cov-2 could be inhibited by compounds that are ample in teas. Many black tea polyphenols, in particular these of Theaflavins-one, Theaflavins-2 and Theaflavins-3 were uncovered to inhibit the SARS CoV-2 replication. In black tea, Theaflavins-3 was the most ample (one.05 for every cent).

“These results suggest that Theaflavins may well be a fantastic starting off stage for the style of additional lively inhibitors for SARS CoV-2 and these compounds are ample in the extract of black tea made from the seedling populations belonging to Camellia L SP as very well as the cultivars designed by the Upasi Tea Exploration Institute,” Shreedharan famous.

He also listed the different other wellbeing benefits of ingesting tea as proved in the research across the globe.